{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:37:23Z","timestamp":1785371843672,"version":"3.55.0"},"reference-count":49,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T00:00:00Z","timestamp":1676160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Rural Health"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>Rural communities in the United States face unique challenges related to the opioid epidemic. This paper explores the substances and substance\u2010related health problems that pose the greatest concern to rural communities that received funding to address the opioid epidemic and examines their reported capacity to address these challenges.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This paper analyzed data collected as part of quarterly progress reporting from multisector consortiums across 2 cohorts of grantees funded to reduce the morbidity and mortality of opioids. Consortium project directors ranked the top 3 issues in their community in each of the following categories: (1) drugs of concern; (2) drugs with the least capacity to address; (3) related problem areas of concern (eg, neonatal abstinence syndrome [NAS]); and (4) related problem areas with the least capacity to address.<\/jats:p><\/jats:sec><jats:sec><jats:title>Findings<\/jats:title><jats:p>Methamphetamines, fentanyl, and alcohol were the substances rated as most problematic in rural communities funded to address the opioid epidemic across all reporting periods. Over 40% of respondents ranked methamphetamine as a top concern <jats:italic>and<\/jats:italic> the substance they had the least capacity to address. This was nearly double the percentage of the next highest\u2010ranked substance (fentanyl). Overdoses, NAS, and viral hepatitis constituted the top\u2010ranking related concerns, with limited capacity to address them.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Multiple drug and concomitant problems coalesced on rural communities during the opioid epidemic. Funding communities to address substance use disorders and related problems of concern, rather than targeting funding toward a specific type of drug, may result in better health outcomes throughout the entire community.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jrh.12743","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T05:39:56Z","timestamp":1676266796000},"page":"795-803","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Rural communities face more than an opioid crisis: Reimagining funding assistance to address polysubstance use, associated health problems, and limited rural service capacity"],"prefix":"10.1111","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7620-7644","authenticated-orcid":false,"given":"Carolyn","family":"Carpenedo Mun","sequence":"first","affiliation":[{"name":"JBS International, Inc.  North Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2790-2288","authenticated-orcid":false,"given":"Heather","family":"Schuler","sequence":"additional","affiliation":[{"name":"JBS International, Inc.  North Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Baker","sequence":"additional","affiliation":[{"name":"Oregon Health and Science University  Portland Oregon USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fraser","family":"Byrne","sequence":"additional","affiliation":[{"name":"Health Resources and Services Administration (HRSA)  Rockville Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bresani","sequence":"additional","affiliation":[{"name":"JBS International, Inc.  North Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Meyers","sequence":"additional","affiliation":[{"name":"JBS International, Inc.  North Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,2,12]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:122556"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-00895-0"},{"key":"e_1_2_11_4_1","unstructured":"CollinsF.Coping with the Collision of Public Health Crises: COVID\u201019 and Substance Use Disorders. July 28 2020.https:\/\/directorsblog.nih.gov\/2020\/04\/21\/coping\u2010with\u2010the\u2010collision\u2010of\u2010public\u2010health\u2010crises\u2010covid\u201019\u2010and\u2010substance\u2010use\u2010disorders"},{"key":"e_1_2_11_5_1","unstructured":"MonnatS.Why Coronavirus Could Hit Rural Areas Harder.Lerner Center for Public Health Promotion;2020."},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826084.2014.891615"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7109a2"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6831e1"},{"key":"e_1_2_11_9_1","unstructured":"OyekaO UllrichF MuellerKJ.Medicare Beneficiary Access to Prescription Drugs in Rural Areas (Rural Policy Brief 2022\u20102).RUPRI Center for Rural Health Policy Analysis;2022."},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.2606"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/jrh.12307"},{"key":"e_1_2_11_12_1","unstructured":"SalakoA UllrichF MuellerKJ.Update: Independently Owned Pharmacy Closures in Rural America 2003\u20132018 (Rural Policy Brief No. 2018\u20102).RUPRI Center for Rural Health Policy Analysis;2018."},{"key":"e_1_2_11_13_1","unstructured":"LazaroE UllrichF MuellerKJ.Update on Rural Independently Owned Pharmacy Closures in the United States 2003\u20132021 (Rural Policy Brief No. 2022\u20133).RUPRI Center for Rural Health Policy Analysis;2022."},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108729"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6802a1"},{"key":"e_1_2_11_16_1","unstructured":"Centers for Disease Control and Prevention.Drug Overdose Deaths.2021. Accessed May 25 2022.https:\/\/www.cdc.gov\/drugoverdose\/data\/statedeaths.html"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2021.306256"},{"issue":"6","key":"e_1_2_11_18_1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/jama.2021.0074","article-title":"Accelerated overdose deaths linked with COVID\u201019","volume":"325","author":"Kuehn BM","year":"2021","journal-title":"JAMA"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.08.029"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2008.06.005"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-00949-3"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6935a1"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6911a4"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108750"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000717"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.2588"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106729"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000260"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.12.030"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2019.305412"},{"key":"e_1_2_11_31_1","unstructured":"NIDA.Rising Stimulant Deaths Show That We Face More Than Just an Opioid Crisis. November 12 2020. Accessed May 25 2022.https:\/\/nida.nih.gov\/about\u2010nida\/noras\u2010blog\/2020\/11\/rising\u2010stimulant\u2010deaths\u2010show\u2010we\u2010face\u2010more\u2010than\u2010just\u2010opioid\u2010crisis"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000465"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2021.1981919"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108307"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.03.010"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1037\/adb0000287"},{"key":"e_1_2_11_37_1","unstructured":"OsterNV PattersonDG SkillmanSM FrognerBK.COVID\u201019 and the Rural Health Workforce: the Impact of Federal Pandemic Funding to Address Workforce Needs.CHWS;2022."},{"key":"e_1_2_11_38_1","unstructured":"MuellerD KaynakO SchulerH et\u00a0al.Understanding the multidimensional facets of stigma experienced by individuals with SUD\/OUD in rural American communities.Poster presented at: The RX Drug Abuse and Heroin Summit Annual Meeting.Atlanta GA;2022."},{"key":"e_1_2_11_39_1","unstructured":"MeyersK KaynakO SchulerH MuellerD BurminghamC.COVID\u201019 and substance use disorder stigma in rural communities: challenges and adaptations to community education and engagement.Paper presented at: The Society of Behavioral Medicine Annual Meeting.Baltimore MD;2022."},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.26544"},{"key":"e_1_2_11_41_1","volume-title":"Expanding Access to Naloxone: A Review of Distribution Strategies","author":"Weiner J","year":"2019"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-019-0352-0"},{"issue":"11","key":"e_1_2_11_43_1","article-title":"Implications of increased access to buprenorphine for medical providers in rural areas: a review of the literature and future directions","volume":"13","author":"Gregory HM","year":"2021","journal-title":"Cureus"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-018-0393-0"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-018-0396-x"},{"key":"e_1_2_11_46_1","volume-title":"Reimagining Rural Policy: Organizing Federal Assistance to Maximize Rural Prosperity","author":"Pipa T","year":"2020"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000767"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17249189"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.22942"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2017.06.008"}],"container-title":["The Journal of Rural Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jrh.12743","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jrh.12743","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jrh.12743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T04:50:00Z","timestamp":1697604600000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jrh.12743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,12]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1111\/jrh.12743"],"URL":"https:\/\/doi.org\/10.1111\/jrh.12743","archive":["Portico"],"relation":{},"ISSN":["0890-765X","1748-0361"],"issn-type":[{"value":"0890-765X","type":"print"},{"value":"1748-0361","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,12]]},"assertion":[{"value":"2023-02-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}